Quick summary

Bhringraj (Eclipta prostrata) is a traditional medicinal herb containing diverse bioactive compounds such as flavonoids, terpenoids, and phenolic acids. It has been studied mainly through in vitro, in vivo, and computational analyses for potential anticancer, anti-inflammatory, antioxidant, and other therapeutic effects. Clinical evidence specific to Bhringraj is limited or lacking, with most findings being preliminary or based on traditional use and phytochemical composition.

What is it?

Bhringraj, also known as Eclipta prostrata, is a flowering plant traditionally used in herbal medicine systems, particularly in South Asia. It is recognized for its varied phytochemicals which are believed to contribute to its medicinal properties.

Traditional uses

  • Traditionally used to promote hair growth and manage hair loss.
  • Used in various cultures for general health support and skin conditions.
  • Applied as part of holistic approaches in Ayurveda and related medical systems.

Active compounds

The key active compounds identified in Bhringraj include:

  • Flavonoids (e.g., kaempferol, apigenin)
  • Terpenoids
  • Phenolic acids

These phytochemicals contribute to its antioxidant, anti-inflammatory, and other biological activities observed in preclinical research.

Potential benefits with evidence levels

  • Potential anticancer activity (Preclinical/computational): In silico studies suggest that compounds in Bhringraj may inhibit targets involved in acute myeloid leukemia (AML), such as FLT3 and PIM1 kinases. Experimental validation is pending. (Islam KMT et al., 2025)
  • Traditional use in hair loss management (Traditional use / insufficient clinical evidence): Ethnopharmacological reports support its use for promoting hair growth, but direct clinical trial data are lacking. (Allam AT et al., 2025)
  • Antioxidant and anti-inflammatory effects (Preclinical): Studies in vitro and in animal models indicate antioxidant and anti-inflammatory activity related to its flavonoids and phenolic content. (Meng X et al., 2023; Phytochemical Analysis, 2018)

Side effects

There are no well-documented adverse effects or toxicity reports specifically associated with Bhringraj in clinical or preclinical literature. Anecdotal traditional use suggests it is generally well tolerated, though formal safety data are lacking.

Drug interactions

No documented drug interactions specific to Bhringraj have been identified. Due to limited clinical data, potential interactions with pharmaceuticals are currently unknown and caution is advised when combining with other medications.

Who should avoid it

  • Individuals who are pregnant or breastfeeding are advised to avoid use of Bhringraj due to lack of safety data.
  • People with medical conditions or those taking medications should consult a healthcare professional before use.
  • Caution is warranted generally because of insufficient high-quality clinical safety data.

Evidence limitations

The available evidence on Bhringraj mainly consists of traditional knowledge, phytochemical analyses, and preclinical studies including computational and animal experiments. Robust human clinical trials, systematic reviews, or meta-analyses specifically evaluating its efficacy and safety are lacking. Therefore, any clinical benefit claims should be regarded as tentative until confirmed by well-designed human research.

References

Last reviewed

April 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. The efficacy and safety of Bhringraj (Eclipta prostrata) have not been fully established through rigorous clinical research. Consult a healthcare professional prior to use, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking medications.